基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Cisplatin,a DNA crosslinking agent,is widely used for the treatment of a variety of solid tumors.Numerous studies have demonstrated that sphingolipid metabolism,which acts as a target for cisplatin treatment,is a highly complex network that consists of sphingolipid signaling molecules and related catalytic enzymes.Ceramide(Cer),which is the central molecule of this network,has been established to induce apoptosis.However,another molecule,sphingosine-1-phosphate(S1P),exerts the opposite function,i.e.,serves as a regulator of pro-survival.Other sphingolipid molecules,including dihydroceramide,ceramide-1-phosphate,glucosylceramide(GluCer),and sphingosine(Sph),or sphingolipid catalytic enzymes such as Sph kinase(SphK),Cer synthase(CerS),and S1P lyase,have also attracted considerable attention,particularly Cer,GluCer,SphK,CerS,and S1P lyase,which have been implicated in cisplatin resistance.This review summarizes specific molecules involved in sphingolipid metabolism and related catalytic enzymes affecting the anticancer effect of cisplatin,particularly in relation to induction of apoptosis and drug resistance.
推荐文章
基于GPU实现SlideShow中的effect和transition
图像处理器
Direct3D
SlideShow
固定功能流水线
可编程流水线
高级渲染语言
顶点渲染
像素渲染
磷酸钙骨水泥/氨磷汀/顺铂复合体体外药物缓释及体内修复骨缺损和抑瘤实验
磷酸钙骨水泥
氨磷汀
顺铂
骨肉瘤
骨缺损
药物缓释
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Sphingolipid metabolism affects the anticancer effect of cisplatin
来源期刊 世界转化医学杂志 学科 医学
关键词 Apoptosis SPHINGOLIPID METABOLISM DRUG resistance CISPLATIN ANTICANCER
年,卷(期) 2016,(1) 所属期刊栏目
研究方向 页码范围 37-45
页数 9页 分类号 R
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2016(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Apoptosis
SPHINGOLIPID
METABOLISM
DRUG
resistance
CISPLATIN
ANTICANCER
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
世界转化医学杂志
其它
2220-6132
北京市朝阳区东四环中路62号楼远洋国际中
出版文献量(篇)
48
总下载数(次)
0
总被引数(次)
0
论文1v1指导